Basic info
Industry
biotechnology research
Sectors
Next-generation antibody drug discovery
Biotechnology
Immunology
Clinical development
Bispecific antibody drugs
Medical
Pharmaceutical
Date founded
1998
Funding rounds raised
Total raised
$55M
from 10 investors over 10 rounds
N
NovImmune raised undisclosed on June 1, 2012
Investors: Reference Capital
N
NovImmune raised $21M on December 17, 2010
Investors: BZ Bank
N
NovImmune raised $55M on May 12, 2009
Investors: BZ Bank, Pictet Asset Management and Aravis
N
NovImmune raised undisclosed on November 16, 2006
Investors: Reference Capital
N
NovImmune raised $46M on June 1, 2006
Investors: BZ Bank, Pictet Asset Management and Aravis
N
NovImmune raised undisclosed on April 15, 2000
Investors: Reference Capital